Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
7 | 106258428 | intron variant | C/T | snv | 5.6E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
7 | 106258428 | intron variant | C/T | snv | 5.6E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
7 | 106258428 | intron variant | C/T | snv | 5.6E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
7 | 106258428 | intron variant | C/T | snv | 5.6E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
0.882 | 0.120 | 7 | 106285307 | intron variant | C/A;T | snv | 0.76 |
|
Female Urogenital Diseases and Pregnancy Complications; Cardiovascular Diseases | 0.020 | 1.000 | 2 | 2015 | 2017 | |||||||
|
0.925 | 0.080 | 7 | 106283804 | intron variant | T/C | snv | 0.26 |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 0.020 | 1.000 | 2 | 2012 | 2015 | |||||||
|
0.925 | 0.080 | 7 | 106283804 | intron variant | T/C | snv | 0.26 |
|
Female Urogenital Diseases and Pregnancy Complications; Cardiovascular Diseases | 0.020 | 1.000 | 2 | 2015 | 2017 | |||||||
|
0.882 | 0.120 | 7 | 106263704 | intron variant | A/G | snv | 0.49 |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 0.020 | 1.000 | 2 | 2008 | 2016 | |||||||
|
1.000 | 0.080 | 7 | 106269615 | intron variant | A/T | snv | 1.1E-02 |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.882 | 0.120 | 7 | 106285307 | intron variant | C/A;T | snv | 0.76 |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.882 | 0.120 | 7 | 106285307 | intron variant | C/A;T | snv | 0.76 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.882 | 0.120 | 7 | 106285307 | intron variant | C/A;T | snv | 0.76 |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.925 | 0.040 | 7 | 106265839 | intron variant | T/A | snv | 1.6E-03 |
|
Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.040 | 7 | 106265839 | intron variant | T/A | snv | 1.6E-03 |
|
Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.040 | 7 | 106276262 | non coding transcript exon variant | T/C | snv | 0.27 |
|
Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.040 | 7 | 106276262 | non coding transcript exon variant | T/C | snv | 0.27 |
|
Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.080 | 7 | 106283804 | intron variant | T/C | snv | 0.26 |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.925 | 0.040 | 7 | 106278476 | intron variant | A/T | snv | 0.64 |
|
Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.040 | 7 | 106278476 | intron variant | A/T | snv | 0.64 |
|
Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.882 | 0.120 | 7 | 106263704 | intron variant | A/G | snv | 0.49 |
|
Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.882 | 0.120 | 7 | 106263704 | intron variant | A/G | snv | 0.49 |
|
Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
1.000 | 0.120 | 7 | 106285832 | 5 prime UTR variant | C/A | snv | 9.5E-02 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.732 | 0.320 | 7 | 106286419 | upstream gene variant | G/A | snv | 0.22 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.732 | 0.320 | 7 | 106286419 | upstream gene variant | G/A | snv | 0.22 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.732 | 0.320 | 7 | 106286419 | upstream gene variant | G/A | snv | 0.22 |
|
Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 |